clinicaltrialsarena16h
South Korean study shows high prevalence of smoking among HIV patients
In South Korea, public health authorities have expressed concern about smoking in HIV patients due to the habit’s high societal acceptance.
clinicaltrialsarena17h
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...
clinicaltrialsarena17h
Maat Pharma Phase III microbiome trial hits endpoints as stock soars
MaaT Pharma has seen its microbiome therapy for patients living with treatment-induced dysbiosis hit its endpoints.
clinicaltrialsarena18h
Contineum concludes enrolment in Phase II multiple sclerosis therapy trial
Contineum Therapeutics has concluded targeted enrolment in a Phase II trial of PIPE-307 for relapsing-remitting multiple sclerosis (RRMS).
clinicaltrialsarena19h
Cristcot‘s Phase III ulcerative colitis suppository trial meets endpoints
The Phase III trial successfully saw patients achieving clinical remission and stopping rectal bleeding within 28 days.
clinicaltrialsarena22h
Viking Therapeutics begins VK2735 Phase II trial for obesity treatment
Viking Therapeutics has begun a Phase II clinical trial of VK2735 aimed at treating metabolic disorders, such as obesity.
clinicaltrialsarena23h
Suven doses first subjects in trial of SUVN-I6107 for cognitive disorders
Suven Life Sciences has announced the dosing of the first subjects in its Phase I clinical trial of SUVN-I6107 to treat cognitive disorders.